Goldman Sachs initiated coverage on ResMed Inc (NYSE:RMD) with a "Buy" rating and a price target of A$48.9, driven by strong growth prospects in its continuous airway pressure (CPAP) therapy segment.

If you're looking to open a high-yield savings account, American Express and Marcus by Goldman Sachs both offer excellent ...

Goldman Sachs Group Inc.'s stock was up 1.3% to $614 a share on Thursday, a record stock price for the investment bank, a day after its stronger-than-expected fourth-quarter profit. If the gains hold ...

Goldman Sachs Group, Inc. (GS) is currently at $612.34, up $6.42 or 1.06% --Would be new all-time high (Based on available data back to May 4, 1999) --Would be the first record close since Nov. 29, ...

Goldman estimates that companies could spend some $1.07 trillion on buying back their own stock this year. On the other side ...

Morgan Stanley's profit increased in the fourth quarter, fueled by a wave of dealmaking and stock sales that drove its ...

Wall Street CEOs voiced confidence on Wednesday that the incoming administration would be business-friendly and good for banks.

Asian markets extended a global rally Thursday after below-forecast US inflation provided a much-needed shot of relief to ...

Goldman Sachs posted its best profit since the third quarter of 2021, driven by bankers who brought in more fees from ...

Goldman Sachs' credit-card partnership with Apple may end before its contract runs out in 2030, Goldman CEO David Solomon ...

Stock markets surged on Wednesday, buoyed by robust US bank earnings and encouraging inflation data from the United States ...

US stocks jumped on Wednesday after consumer price data showed inflation continues to slow. Strong bank earnings also helped ...